Abstract
A new phosphotyrosyl mimetic 4-(α-hydroxymalonyl)phenylalanine and its incorporation into a Grb2 SH2 domain-binding tripeptide are presented. In whole-cell studies using malonyl ethyl ester prodrug derivatives, it was observed that the 4-(α-hydroxymalonyl)phenylalanyl-containing peptide exhibited greater efficacy than the nonhydroxylated 4-(malonyl)phenylalanyl- containing congener in blocking the association of Grb2 with activated erbB-2 tyrosine kinase. These results are consistent with de-esterification and at least partial intracellular decarboxylation.
Original language | English (US) |
---|---|
Pages (from-to) | 5369-5372 |
Number of pages | 4 |
Journal | Journal of Medicinal Chemistry |
Volume | 48 |
Issue number | 16 |
DOIs | |
State | Published - Aug 11 2005 |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery